Cargando…

Editorial: Novelties in the therapeutic approaches for chronic heart failure: cardiovascular targets and beyond, volume II

Detalles Bibliográficos
Autores principales:	Iacoviello, Massimo, Sorgente, Antonio, Passantino, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434248/ https://www.ncbi.nlm.nih.gov/pubmed/37600025 http://dx.doi.org/10.3389/fcvm.2023.1256656

Ejemplares similares

Editorial: Novelties in the Therapeutic Approaches for Chronic Heart Failure: Cardiovascular Targets and Beyond
por: Sorgente, Antonio, et al.
Publicado: (2022)

Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets
por: Correale, Michele, et al.
Publicado: (2023)

Editorial: The role of sex in heart failure and transplantation, volume II
por: Ayesta, Ana, et al.
Publicado: (2023)

Editorial: Epigenetic regulation in cardiovascular diseases, volume II
por: Xu, Suowen, et al.
Publicado: (2023)

Editorial: Cardiovascular adaptation to extreme environment, volume II
por: Pingitore, Alessandro, et al.
Publicado: (2023)

Editorial: Molecular and cellular mechanisms of heart failure: pathophysiology, pathogenesis and therapeutics
por: Lal, Sean, et al.
Publicado: (2023)

Iron Deficiency: A New Target for Patients With Heart Failure
por: Rizzo, Caterina, et al.
Publicado: (2021)

Editorial: Women in cardiovascular therapeutics
por: Yin, Liya, et al.
Publicado: (2023)

The Future of Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure
por: Passantino, Andrea, et al.
Publicado: (2021)

Editorial: Lipids and inflammation in health and disease, volume II
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
por: Xu, Keman, et al.
Publicado: (2023)

Editorial: The Role of Sex in Heart Failure and Transplantation
por: Martínez-Sellés, Manuel, et al.
Publicado: (2021)

Editorial: Highlights in Heart Failure and Transplantation in 2021
por: Cameli, Matteo, et al.
Publicado: (2022)

Editorial: Non-coding RNAs in heart failure
por: Booz, George W., et al.
Publicado: (2022)

Editorial: Novel and emerging therapies in heart failure
por: Giamouzis, Grigorios, et al.
Publicado: (2023)

Editorial: Insights in heart failure and transplantation: 2022
por: Cameli, Matteo, et al.
Publicado: (2023)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Editorial: Novel Risk Predicting System for Heart Failure
por: Liu, Chen, et al.
Publicado: (2022)

Editorial: Edema in heart failure with reduced ejection fraction
por: Gladysheva, Inna P., et al.
Publicado: (2023)

Editorial: Case reports in heart failure and transplantation: 2022
por: Cameli, Matteo, et al.
Publicado: (2023)

Editorial: Advances in cardiac imaging and heart failure management
por: Mandoli, Giulia Elena, et al.
Publicado: (2023)

Native T1 is predictive of cardiovascular death/heart failure events and all-cause mortality irrespective of the patient’s volume status
por: Treiber, Julia, et al.
Publicado: (2023)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Editorial: Epigenetics in Heart Failure Developing: The Orchestra of Etiology and Comorbidities
por: Berezin, Alexander E., et al.
Publicado: (2022)

Editorial: Improving Early Detection and Risk Prediction in Heart Failure
por: Tragante, Vinicius, et al.
Publicado: (2022)

Editorial: Advances and challenges in remote monitoring of patients with heart failure
por: Perl, Leor, et al.
Publicado: (2022)

Editorial: Novel phenotyping and risk stratification strategies for heart failure
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2023)

Editorial: Long-term perspectives in advanced heart failure therapies
por: Schoenrath, Felix, et al.
Publicado: (2023)

Editorial: Machine learning and data science in heart failure and stroke
por: Roever, Leonardo, et al.
Publicado: (2023)

Editorial: Current and future role of artificial intelligence in cardiac imaging, volume II
por: Leiner, Tim, et al.
Publicado: (2023)

Editorial: Cardiovascular involvement during sepsis: therapeutic and prognostic consequences
por: Innocenti, F., et al.
Publicado: (2023)

Triglyceride–Glucose Index and Extracellular Volume Fraction in Patients With Heart Failure
por: Yang, Shaomin, et al.
Publicado: (2021)

Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
por: Rubattu, Speranza, et al.
Publicado: (2020)

Editorial: Pathophysiological and clinical insights for atrial fibrillation/flutter or heart failure
por: Lin, Chun, et al.
Publicado: (2023)

The interstitial compartment as a therapeutic target in heart failure
por: Aronson, Doron
Publicado: (2022)

Mitochondrial dysfunction in heart failure and its therapeutic implications
por: Liu, Miaosen, et al.
Publicado: (2022)

Editorial: Insights in heart surgery: 2022
por: Bonacchi, Massimo, et al.
Publicado: (2023)

Editorial: Comprehensive risk prediction in cardiomyopathies: new genetic and imaging markers of risk, volume II
por: Cardim, Nuno, et al.
Publicado: (2023)

Editorial: Electrical management of heart failure: shaping the future of cardiac pacing and electrophysiology
por: Bressi, Edoardo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_704513kb88q9c76dd12462b1sc